Company Profile
MedPacto provides the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.
#1299 ๐ฐ๐ท KR
KOSDAQยท235980.KQ
โฉ2450.0000
$1.69ยทโฌ1.48
-29.60% (24h)
Last updated: 1 second ago
Market Cap
โฉ83.97B
$57.86M ยท โฌ50.76M
Volume (24h)
2.19M shrsยท โฉ5.37B
$3.70M ยท โฌ3.24M
Last Close (7D)
โฉ2450.00
$1.69 ยท โฌ1.48
MedPacto provides the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.
52-Week Range
SEC filings for this ticker are not available yet.
Americas
Europe
Asia